{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:29:04Z","timestamp":1790832544125,"version":"4.1.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T00:00:00Z","timestamp":1507766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Natural Killer (NK) cells employ activating receptors like the Natural Cytotoxicity Receptors (NCRs: NKp30, NKp44 and NKp46), of which only NKp46 has a mouse orthologue (Ncr1), to eliminate abnormal cells. NKp46\/Ncr1 is considered a selective marker for NK cells, although it is also found on a subset of ILCs, where it appears to be without function. The influenza virus hemagglutinin (HA) was the first ligand identified for Ncr1\/NKp46 followed by other viral, bacterial and even fungal ligands. NKp46\/Ncr1 also recognizes unknown self and tumor ligands. Here we describe the generation of a transgenic mouse where the Ncr1 gene is expressed in the Rosa locus, preceded by a floxed stop sequence allowing Ncr1\/NKp46 expression in various tissues upon crossing with Cre transgenic mouse lines. Surprisingly, while several crossings were attempted, Ncr1 overexpression was successful only where cre recombinase expression was dependent on the Ncr1 promoter. Ncr1 overexpression in NK cells increased NK cell immunity in two hallmark Ncr1 related pathologies, influenza virus infection and B16 melanoma. These data suggest that increasing NK cell cytotoxicity by enforced NKp46\/Ncr1 expression serves as a potential therapeutic opportunity for the treatment of various pathologies, and in immunotherapy.<\/jats:p>","DOI":"10.1038\/s41598-017-12998-w","type":"journal-article","created":{"date-parts":[[2017,10,6]],"date-time":"2017-10-06T10:25:05Z","timestamp":1507285505000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Increased NK cell immunity in a transgenic mouse model of NKp46 overexpression"],"prefix":"10.1038","volume":"7","author":[{"given":"Ariella","family":"Glasner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batya","family":"Isaacson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Viukov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzahi","family":"Neuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehemya","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Mandelboim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Sexl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2042-9974","authenticated-orcid":false,"given":"Jacob H.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofer","family":"Mandelboim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,12]]},"reference":[{"key":"12998_CR1","doi-asserted-by":"publisher","first-page":"915","DOI":"10.4049\/jimmunol.171.2.915","volume":"171","author":"H Achdout","year":"2003","unstructured":"Achdout, H. et al. Enhanced recognition of human NK receptors after influenza virus infection. J Immunol \n                           171, 915\u2013923 (2003).","journal-title":"J Immunol"},{"key":"12998_CR2","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1128\/JVI.00870-08","volume":"82","author":"H Achdout","year":"2008","unstructured":"Achdout, H., Manaster, I. & Mandelboim, O. Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins. Journal of virology \n                           82, 8030\u20138037, https:\/\/doi.org\/10.1128\/JVI.00870-08 (2008).","journal-title":"Journal of virology"},{"key":"12998_CR3","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1128\/JVI.02289-09","volume":"84","author":"H Achdout","year":"2010","unstructured":"Achdout, H. et al. Killing of avian and Swine influenza virus by natural killer cells. Journal of virology \n                           84, 3993\u20134001, https:\/\/doi.org\/10.1128\/JVI.02289-09 (2010).","journal-title":"Journal of virology"},{"key":"12998_CR4","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1002\/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A","volume":"31","author":"TI Arnon","year":"2001","unstructured":"Arnon, T. I. et al. Recognition of viral hemagglutinins by NKp44 but not by NKp30. European journal of immunology \n                           31, 2680\u20132689, https:\/\/doi.org\/10.1002\/1521-4141 (2001).","journal-title":"European journal of immunology"},{"key":"12998_CR5","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.1084\/jem.20100921","volume":"207","author":"M Babic","year":"2010","unstructured":"Babic, M. et al. Cytomegalovirus immunoevasin reveals the physiological role of \u201cmissing self\u201d recognition in natural killer cell dependent virus control in vivo. The Journal of experimental medicine \n                           207, 2663\u20132673, https:\/\/doi.org\/10.1084\/jem.20100921 (2010).","journal-title":"The Journal of experimental medicine"},{"key":"12998_CR6","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.celrep.2013.03.034","volume":"3","author":"Y Bar-On","year":"2013","unstructured":"Bar-On, Y. et al. Neuraminidase-mediated, NKp46-dependent immune-evasion mechanism of influenza viruses. Cell reports \n                           3, 1044\u20131050, https:\/\/doi.org\/10.1016\/j.celrep.2013.03.034 (2013).","journal-title":"Cell reports"},{"key":"12998_CR7","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1093\/infdis\/jiu094","volume":"210","author":"Y Bar-On","year":"2014","unstructured":"Bar-On, Y., Seidel, E., Tsukerman, P., Mandelboim, M. & Mandelboim, O. Influenza virus uses its neuraminidase protein to evade the recognition of two activating NK cell receptors. The Journal of infectious diseases \n                           210, 410\u2013418, https:\/\/doi.org\/10.1093\/infdis\/jiu094 (2014).","journal-title":"The Journal of infectious diseases"},{"key":"12998_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/ni1322","volume":"7","author":"R Gazit","year":"2006","unstructured":"Gazit, R. et al. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nature immunology \n                           7, 517\u2013523, https:\/\/doi.org\/10.1038\/ni1322 (2006).","journal-title":"Nature immunology"},{"key":"12998_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036837","volume":"7","author":"A Glasner","year":"2012","unstructured":"Glasner, A. et al. Elucidating the mechanisms of influenza virus recognition by Ncr1. PloS one \n                           7, e36837, https:\/\/doi.org\/10.1371\/journal.pone.0036837 (2012).","journal-title":"PloS one"},{"key":"12998_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002195","volume":"7","author":"M Jarahian","year":"2011","unstructured":"Jarahian, M. et al. Modulation of NKp30- and NKp46-Mediated Natural Killer Cell Responses by Poxviral Hemagglutinin. PLoS pathogens \n                           7, e1002195, https:\/\/doi.org\/10.1371\/journal.ppat.1002195 (2011).","journal-title":"PLoS pathogens"},{"key":"12998_CR11","doi-asserted-by":"publisher","first-page":"8108","DOI":"10.1128\/JVI.00211-09","volume":"83","author":"M Jarahian","year":"2009","unstructured":"Jarahian, M. et al. Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase. Journal of virology \n                           83, 8108\u20138121, https:\/\/doi.org\/10.1128\/JVI.00211-09 (2009).","journal-title":"Journal of virology"},{"key":"12998_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002601","volume":"8","author":"S Chaushu","year":"2012","unstructured":"Chaushu, S. et al. Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease. PLoS pathogens \n                           8, e1002601, https:\/\/doi.org\/10.1371\/journal.ppat.1002601 (2012).","journal-title":"PLoS pathogens"},{"key":"12998_CR13","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.chom.2013.11.004","volume":"14","author":"C Gur","year":"2013","unstructured":"Gur, C. et al. Natural killer cell-mediated host defense against uropathogenic E. coli is counteracted by bacterial hemolysinA-dependent killing of NK cells. Cell host & microbe \n                           14, 664\u2013674, https:\/\/doi.org\/10.1016\/j.chom.2013.11.004 (2013).","journal-title":"Cell host & microbe"},{"key":"12998_CR14","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.chom.2016.09.008","volume":"20","author":"A Vitenshtein","year":"2016","unstructured":"Vitenshtein, A. et al. NK Cell Recognition of Candida glabrata through Binding of NKp46 and NCR1 to Fungal Ligands Epa1, Epa6, and Epa7. Cell host & microbe \n                           20, 527\u2013534, https:\/\/doi.org\/10.1016\/j.chom.2016.09.008 (2016).","journal-title":"Cell host & microbe"},{"key":"12998_CR15","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1182\/blood-2003-05-1716","volume":"103","author":"TI Arnon","year":"2004","unstructured":"Arnon, T. I. et al. The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood \n                           103, 664\u2013672, https:\/\/doi.org\/10.1182\/blood-2003-05-1716 (2004).","journal-title":"Blood"},{"key":"12998_CR16","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.4049\/jimmunol.0901644","volume":"184","author":"M Elboim","year":"2010","unstructured":"Elboim, M. et al. Tumor immunoediting by NKp46. J Immunol \n                           184, 5637\u20135644, https:\/\/doi.org\/10.4049\/jimmunol.0901644 (2010).","journal-title":"J Immunol"},{"key":"12998_CR17","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.4049\/jimmunol.1102461","volume":"188","author":"A Glasner","year":"2012","unstructured":"Glasner, A. et al. Recognition and prevention of tumor metastasis by the NK receptor NKp46\/NCR1. J Immunol \n                           188, 2509\u20132515, https:\/\/doi.org\/10.4049\/jimmunol.1102461 (2012).","journal-title":"J Immunol"},{"key":"12998_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/celldisc.2015.36","volume":"1","author":"A Glasner","year":"2015","unstructured":"Glasner, A. et al. Identification of putative novel O-glycosylations in the NK killer receptor Ncr1 essential for its activity. Cell Discov \n                           1, 15036, https:\/\/doi.org\/10.1038\/celldisc.2015.36 (2015).","journal-title":"Cell Discov"},{"key":"12998_CR19","doi-asserted-by":"publisher","first-page":"3959","DOI":"10.4049\/jimmunol.1501234","volume":"195","author":"A Glasner","year":"2015","unstructured":"Glasner, A. et al. Expression, Function, and Molecular Properties of the Killer Receptor Ncr1-Noe. J Immunol \n                           195, 3959\u20133969, https:\/\/doi.org\/10.4049\/jimmunol.1501234 (2015).","journal-title":"J Immunol"},{"key":"12998_CR20","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.4049\/jimmunol.0801878","volume":"182","author":"GG Halfteck","year":"2009","unstructured":"Halfteck, G. G. et al. Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46\/NCR1. J Immunol \n                           182, 2221\u20132230, https:\/\/doi.org\/10.4049\/jimmunol.0801878 (2009).","journal-title":"J Immunol"},{"key":"12998_CR21","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1016\/j.celrep.2014.05.011","volume":"7","author":"H Ghadially","year":"2014","unstructured":"Ghadially, H. et al. NK cell receptor NKp46 regulates graft-versus-host disease. Cell reports \n                           7, 1809\u20131814, https:\/\/doi.org\/10.1016\/j.celrep.2014.05.011 (2014).","journal-title":"Cell reports"},{"key":"12998_CR22","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/gutjnl-2011-301400","volume":"61","author":"C Gur","year":"2012","unstructured":"Gur, C. et al. NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut \n                           61, 885\u2013893, https:\/\/doi.org\/10.1136\/gutjnl-2011-301400 (2012).","journal-title":"Gut"},{"key":"12998_CR23","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.4049\/jimmunol.1101269","volume":"187","author":"C Gur","year":"2011","unstructured":"Gur, C. et al. Recognition and Killing of Human and Murine Pancreatic {beta} Cells by the NK Receptor NKp46. J Immunol \n                           187, 3096\u20133103, https:\/\/doi.org\/10.4049\/jimmunol.1101269 (2011).","journal-title":"J Immunol"},{"key":"12998_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0074033","volume":"8","author":"C Gur","year":"2013","unstructured":"Gur, C. et al. The expression of the beta cell-derived autoimmune ligand for the killer receptor nkp46 is attenuated in type 2 diabetes. PloS one \n                           8, e74033, https:\/\/doi.org\/10.1371\/journal.pone.0074033 (2013).","journal-title":"PloS one"},{"key":"12998_CR25","doi-asserted-by":"publisher","first-page":"3006","DOI":"10.1002\/eji.201343388","volume":"43","author":"H Ghadially","year":"2013","unstructured":"Ghadially, H. et al. NKp46 regulates allergic responses. European journal of immunology \n                           43, 3006\u20133016, https:\/\/doi.org\/10.1002\/eji.201343388 (2013).","journal-title":"European journal of immunology"},{"key":"12998_CR26","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm1452","volume":"12","author":"J Hanna","year":"2006","unstructured":"Hanna, J. et al. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nature medicine \n                           12, 1065\u20131074, https:\/\/doi.org\/10.1038\/nm1452 (2006).","journal-title":"Nature medicine"},{"key":"12998_CR27","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.it.2013.01.003","volume":"34","author":"J Koch","year":"2013","unstructured":"Koch, J., Steinle, A., Watzl, C. & Mandelboim, O. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends in immunology \n                           34, 182\u2013191, https:\/\/doi.org\/10.1016\/j.it.2013.01.003 (2013).","journal-title":"Trends in immunology"},{"key":"12998_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1046\/j.1365-3083.2002.01053.x","volume":"55","author":"K Karre","year":"2002","unstructured":"Karre, K. NK cells, MHC class I molecules and the missing self. Scandinavian journal of immunology \n                           55, 221\u2013228 (2002).","journal-title":"Scandinavian journal of immunology"},{"key":"12998_CR29","doi-asserted-by":"publisher","unstructured":"Cantoni, C. et al. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. European journal of immunology \n                           29, 3148\u20133159, https:\/\/doi.org\/10.1002\/(SICI)1521-4141 (1999).","DOI":"10.1002\/(SICI)1521-4141"},{"key":"12998_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","volume":"7","author":"PR Crocker","year":"2007","unstructured":"Crocker, P. R., Paulson, J. C. & Varki, A. Siglecs and their roles in the immune system. Nature reviews. Immunology \n                           7, 255\u2013266, https:\/\/doi.org\/10.1038\/nri2056 (2007).","journal-title":"Nature reviews. Immunology"},{"key":"12998_CR31","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.4049\/jimmunol.0903347","volume":"185","author":"D Lankry","year":"2010","unstructured":"Lankry, D. et al. Expression and function of CD300 in NK cells. J Immunol \n                           185, 2877\u20132886, https:\/\/doi.org\/10.4049\/jimmunol.0903347 (2010).","journal-title":"J Immunol"},{"key":"12998_CR32","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.4049\/jimmunol.168.6.2803","volume":"168","author":"G Markel","year":"2002","unstructured":"Markel, G. et al. CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity. J Immunol \n                           168, 2803\u20132810 (2002).","journal-title":"J Immunol"},{"key":"12998_CR33","doi-asserted-by":"publisher","first-page":"17858","DOI":"10.1073\/pnas.0903474106","volume":"106","author":"N Stanietsky","year":"2009","unstructured":"Stanietsky, N. et al. The interaction of TIGIT with PVR and PVRL2 inhibits human NK cell cytotoxicity. Proceedings of the National Academy of Sciences of the United States of America \n                           106, 17858\u201317863, https:\/\/doi.org\/10.1073\/pnas.0903474106 (2009).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"12998_CR34","doi-asserted-by":"publisher","first-page":"15369","DOI":"10.18632\/oncotarget.8085","volume":"7","author":"Y Bauman","year":"2016","unstructured":"Bauman, Y. et al. Downregulation of the stress-induced ligand ULBP1 following SV40 infection confers viral evasion from NK cell cytotoxicity. Oncotarget \n                           7, 15369\u201315381, https:\/\/doi.org\/10.18632\/oncotarget.8085 (2016).","journal-title":"Oncotarget"},{"key":"12998_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.chom.2011.01.008","volume":"9","author":"Y Bauman","year":"2011","unstructured":"Bauman, Y. et al. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell host & microbe \n                           9, 93\u2013102, https:\/\/doi.org\/10.1016\/j.chom.2011.01.008 (2011).","journal-title":"Cell host & microbe"},{"key":"12998_CR36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.chom.2009.03.003","volume":"5","author":"D Nachmani","year":"2009","unstructured":"Nachmani, D., Stern-Ginossar, N., Sarid, R. & Mandelboim, O. Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell host & microbe \n                           5, 376\u2013385, https:\/\/doi.org\/10.1016\/j.chom.2009.03.003 (2009).","journal-title":"Cell host & microbe"},{"key":"12998_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003963","volume":"10","author":"D Nachmani","year":"2014","unstructured":"Nachmani, D. et al. MicroRNA editing facilitates immune elimination of HCMV infected cells. PLoS pathogens \n                           10, e1003963, https:\/\/doi.org\/10.1371\/journal.ppat.1003963 (2014).","journal-title":"PLoS pathogens"},{"key":"12998_CR38","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/ni.1642","volume":"9","author":"N Stern-Ginossar","year":"2008","unstructured":"Stern-Ginossar, N. et al. Human microRNAs regulate stress-induced immune responses mediated by the receptor NKG2D. Nature immunology \n                           9, 1065\u20131073, https:\/\/doi.org\/10.1038\/ni.1642 (2008).","journal-title":"Nature immunology"},{"key":"12998_CR39","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1038\/35059110","volume":"409","author":"O Mandelboim","year":"2001","unstructured":"Mandelboim, O. et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature \n                           409, 1055\u20131060, https:\/\/doi.org\/10.1038\/35059110 (2001).","journal-title":"Nature"},{"key":"12998_CR40","doi-asserted-by":"publisher","unstructured":"Diab, M. et al. NK-cell receptors NKp46 and NCR1 control human metapneumovirus infection. European journal of immunology, https:\/\/doi.org\/10.1002\/eji.201646756 (2017).","DOI":"10.1002\/eji.201646756"},{"key":"12998_CR41","doi-asserted-by":"publisher","unstructured":"Diab, M. et al. Suppression of human metapneumovirus (HMPV) infection by the innate sensing gene CEACAM1. Oncotarget, https:\/\/doi.org\/10.18632\/oncotarget.11979 (2016).","DOI":"10.18632\/oncotarget.11979"},{"key":"12998_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ni.1834","volume":"11","author":"C Gur","year":"2010","unstructured":"Gur, C. et al. The activating receptor NKp46 is essential for the development of type 1 diabetes. Nature immunology \n                           11, 121\u2013128, https:\/\/doi.org\/10.1038\/ni.1834 (2010).","journal-title":"Nature immunology"},{"key":"12998_CR43","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.immuni.2015.01.010","volume":"42","author":"C Gur","year":"2015","unstructured":"Gur, C. et al. Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors from Immune Cell Attack. Immunity \n                           42, 344\u2013355, https:\/\/doi.org\/10.1016\/j.immuni.2015.01.010 (2015).","journal-title":"Immunity"},{"key":"12998_CR44","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.immuni.2008.02.016","volume":"28","author":"N Guerra","year":"2008","unstructured":"Guerra, N. et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity \n                           28, 571\u2013580, https:\/\/doi.org\/10.1016\/j.immuni.2008.02.016 (2008).","journal-title":"Immunity"},{"key":"12998_CR45","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.immuni.2009.06.017","volume":"31","author":"B Zafirova","year":"2009","unstructured":"Zafirova, B. et al. Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity \n                           31, 270\u2013282, https:\/\/doi.org\/10.1016\/j.immuni.2009.06.017 (2009).","journal-title":"Immunity"},{"key":"12998_CR46","doi-asserted-by":"publisher","first-page":"5025","DOI":"10.1182\/blood-2012-12-471607","volume":"121","author":"S Sheppard","year":"2013","unstructured":"Sheppard, S. et al. Characterization of a novel NKG2D and NKp46 double-mutant mouse reveals subtle variations in the NK cell repertoire. Blood \n                           121, 5025\u20135033, https:\/\/doi.org\/10.1182\/blood-2012-12-471607 (2013).","journal-title":"Blood"},{"key":"12998_CR47","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1182\/blood-2010-06-291633","volume":"117","author":"E Eckelhart","year":"2011","unstructured":"Eckelhart, E. et al. A novel Ncr1-Cre mouse reveals the essential role of STAT5 for NK-cell survival and development. Blood \n                           117, 1565\u20131573, https:\/\/doi.org\/10.1182\/blood-2010-06-291633 (2011).","journal-title":"Blood"},{"key":"12998_CR48","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1126\/science.342.6165.1432","volume":"342","author":"J Couzin-Frankel","year":"2013","unstructured":"Couzin-Frankel, J. Breakthrough of the year 2013. Cancer immunotherapy. Science \n                           342, 1432\u20131433, https:\/\/doi.org\/10.1126\/science.342.6165.1432 (2013).","journal-title":"Cancer immunotherapy. Science"},{"key":"12998_CR49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nrc3237","volume":"12","author":"M Vanneman","year":"2012","unstructured":"Vanneman, M. & Dranoff, G. Combining immunotherapy and targeted therapies in cancer treatment. Nature reviews. Cancer \n                           12, 237\u2013251, https:\/\/doi.org\/10.1038\/nrc3237 (2012).","journal-title":"Nature reviews. Cancer"},{"key":"12998_CR50","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1076514","volume":"298","author":"ME Dudley","year":"2002","unstructured":"Dudley, M. E. et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science \n                           298, 850\u2013854, https:\/\/doi.org\/10.1126\/science.1076514 (2002).","journal-title":"Science"},{"key":"12998_CR51","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.immuni.2004.07.018","volume":"21","author":"JM Dal Porto","year":"2004","unstructured":"Dal Porto, J. M., Burke, K. & Cambier, J. C. Regulation of BCR signal transduction in B-1 cells requires the expression of the Src family kinase Lck. Immunity \n                           21, 443\u2013453, https:\/\/doi.org\/10.1016\/j.immuni.2004.07.018 (2004).","journal-title":"Immunity"},{"key":"12998_CR52","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/intimm\/1.1.94","volume":"1","author":"H Yagita","year":"1989","unstructured":"Yagita, H. et al. CD2 expression in murine B cell lineage. International immunology \n                           1, 94\u201398 (1989).","journal-title":"International immunology"},{"key":"12998_CR53","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1007\/s00262-010-0904-3","volume":"59","author":"EG Iliopoulou","year":"2010","unstructured":"Iliopoulou, E. G. et al. A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer. Cancer immunology, immunotherapy: CII \n                           59, 1781\u20131789, https:\/\/doi.org\/10.1007\/s00262-010-0904-3 (2010).","journal-title":"Cancer immunology, immunotherapy: CII"},{"key":"12998_CR54","first-page":"1861","volume":"24","author":"E Ishikawa","year":"2004","unstructured":"Ishikawa, E. et al. Autologous natural killer cell therapy for human recurrent malignant glioma. Anticancer research \n                           24, 1861\u20131871 (2004).","journal-title":"Anticancer research"},{"key":"12998_CR55","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1182\/blood-2006-05-024315","volume":"109","author":"A Lundqvist","year":"2007","unstructured":"Lundqvist, A., McCoy, J. P., Samsel, L. & Childs, R. Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors. Blood \n                           109, 3603\u20133606, https:\/\/doi.org\/10.1182\/blood-2006-05-024315 (2007).","journal-title":"Blood"},{"key":"12998_CR56","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","volume":"105","author":"JS Miller","year":"2005","unstructured":"Miller, J. S. et al. Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer. Blood \n                           105, 3051\u20133057, https:\/\/doi.org\/10.1182\/blood-2004-07-2974 (2005).","journal-title":"Blood"},{"key":"12998_CR57","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1172\/JCI36022","volume":"119","author":"T Lakshmikanth","year":"2009","unstructured":"Lakshmikanth, T. et al. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. The Journal of clinical investigation \n                           119, 1251\u20131263, https:\/\/doi.org\/10.1172\/JCI36022 (2009).","journal-title":"The Journal of clinical investigation"},{"key":"12998_CR58","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1126\/science.1215621","volume":"335","author":"E Narni-Mancinelli","year":"2012","unstructured":"Narni-Mancinelli, E. et al. Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses. Science \n                           335, 344\u2013348, https:\/\/doi.org\/10.1126\/science.1215621 (2012).","journal-title":"Science"},{"key":"12998_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/srep40944","volume":"7","author":"A Glasner","year":"2017","unstructured":"Glasner, A., Isaacson, B. & Mandelboim, O. Expression and function of NKp46 W32R: the human homologous protein of mouse NKp46 W32R (Noe). Scientific reports \n                           7, 40944, https:\/\/doi.org\/10.1038\/srep40944 (2017).","journal-title":"Scientific reports"}],"updated-by":[{"DOI":"10.1038\/s41598-017-12998-w","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000}},{"DOI":"10.1038\/s41598-026-39507-2","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12998-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12998-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12998-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T11:13:33Z","timestamp":1772709213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-12998-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,12]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["12998"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-12998-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,12]]},"assertion":[{"value":"5 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ExpressionOfConcern","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An Editorial Expression of Concern to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-39507-2","URL":"https:\/\/doi.org\/10.1038\/s41598-026-39507-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13090"}}